ACUCLINIC BRUSSELS: what changed
What changed
ACUCLINIC BRUSSELS
filed annual accounts (NBB)
Net result for the year
€16,151
2024 · -€21,696+€37,847
Equity
€14,455
2024 · -€1,696+€16,151
Cash
€10,055
2024 · €4,111+€5,944
Balance sheet total
€814,251
2024 · €828,121-€13,870
Largest movements
Assets
- Tangible fixed assets -€19,814
down €19,814 (-2.4%), from €823,024 to €803,209
Equity and liabilities
- Debts after one year -€27,841
down €27,841 (-3.7%), from €747,073 to €719,231
- Profit (loss) carried forward +€16,151
up €16,151 (+74.4%), from -€21,696 to -€5,545
Income statement
- Depreciation -€38,114
down €38,114 (-65.1%), from €58,579 to €20,465
- Gross operating margin -€20,398
down €20,398 (-23.7%), from €86,085 to €65,687
- Financial charges -€19,408
down €19,408 (-41.7%), from €46,594 to €27,186
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€21,696
Gross operating margin
-€20,398
Depreciation
+€38,114
Other operating charges
+€723
Financial charges
+€19,408
Result 2025
€16,151
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€33,216
Investment
-€650
Financing
-€26,621
Cash 2024
€4,111
From operations (derived)
+€33,216
Net result for the year
+€16,151
Depreciation
+€20,465
Deferred charges and accrued income
-€0
Trade debts
-€1,013
Other debts
-€2,488
Accrued charges and deferred income
+€101
Investment (derived)
-€650
Investment in fixed assets (net)
-€650
Financing
-€26,621
Debts after one year
-€27,841
Current portion of long-term debt
+€1,220
Cash 2025
€10,055
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €828,121 | €814,251 | -€13,870 | -1.7% |
| Fixed assets | 21/28 | €823,964 | €804,149 | -€19,814 | -2.4% |
| Tangible fixed assets | 22/27 | €823,024 | €803,209 | -€19,814 | -2.4% |
| Land and buildings | 22 | €823,024 | €803,209 | -€19,814 | -2.4% |
| Financial fixed assets | 28 | €940 | €940 | = | 0.0% |
| Current assets | 29/58 | €4,157 | €10,102 | +€5,944 | +143% |
| Cash at bank and in hand | 54/58 | €4,111 | €10,055 | +€5,944 | +145% |
| Deferred charges and accrued income | 490/1 | €47 | €47 | +€0 | +0.9% |
| Total equity and liabilities | 10/49 | €828,121 | €814,251 | -€13,870 | -1.7% |
| Equity | 10/15 | -€1,696 | €14,455 | +€16,151 | |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€21,696 | -€5,545 | +€16,151 | +74.4% |
| Amounts payable | 17/49 | €829,817 | €799,796 | -€30,021 | -3.6% |
| Amounts payable after more than one year | 17 | €747,073 | €719,231 | -€27,841 | -3.7% |
| Financial debts | 170/4 | €747,073 | €719,231 | -€27,841 | -3.7% |
| Amounts payable within one year | 42/48 | €78,699 | €76,418 | -€2,281 | -2.9% |
| Current portion of amounts payable after more than one year | 42 | €32,323 | €33,543 | +€1,220 | +3.8% |
| Trade debts | 44 | €1,462 | €450 | -€1,013 | -69.2% |
| Suppliers | 440/4 | €1,462 | €450 | -€1,013 | -69.2% |
| Other amounts payable | 47/48 | €44,913 | €42,425 | -€2,488 | -5.5% |
| Accrued charges and deferred income | 492/3 | €4,046 | €4,147 | +€101 | +2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €58,579 | €20,465 | -€38,114 | -65.1% |
| Other operating charges | 640/8 | €2,609 | €1,886 | -€723 | -27.7% |
| Gross operating margin | 9900 | €86,085 | €65,687 | -€20,398 | -23.7% |
| Operating profit (loss) | 9901 | €24,898 | €43,337 | +€18,439 | +74.1% |
| Financial charges | 65/66B | €46,594 | €27,186 | -€19,408 | -41.7% |
| Recurring financial charges | 65 | €46,594 | €27,186 | -€19,408 | -41.7% |
| Profit (loss) for the period before taxes | 9903 | -€21,696 | €16,151 | +€37,847 | |
| Profit (loss) for the period | 9904 | -€21,696 | €16,151 | +€37,847 | |
| Profit (loss) for the period to be appropriated | 9905 | -€21,696 | €16,151 | +€37,847 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.